Janux Therapeutics (JANX) Times Interest Earned (2020 - 2026)
Janux Therapeutics' (JANX) quarterly Times Interest Earned came in at -$1.2 in Q1 2026, down 351.23% year-on-year from $0.48 in Q1 2025, and down 263.86% on a QoQ basis from -$0.33 in Q3 2025.
Janux Therapeutics (JANX) Times Interest Earned (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 7 years of Times Interest Earned data on file, last reported at -$1.2 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 351.23% year-over-year to -$1.2 in Q1 2026; TTM through Mar 2026 was -$5.51, a 536.12% decrease from a year earlier, with the FY2025 full-year figure at -$5.33, down 1848.8% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$1.2, down from -$0.33 in the prior quarter.
- Over the last five years, Times Interest Earned for JANX reached as high as -$0.05 in Q2 2024 and fell as low as -$53.1 in Q4 2022.
- Historically, Times Interest Earned has averaged -$4.22 across 5 years, with a median of -$0.46 in 2022.
- Across the five-year window, Times Interest Earned jumped 91.5% in 2024 and plunged 849.0% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$53.1 in 2022, then surged by 98.02% to -$1.05 in 2023, then surged by 89.1% to -$0.11 in 2024, then slumped by 188.57% to -$0.33 in 2025, then tumbled by 263.86% to -$1.2 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$1.2 in Q1 2026, -$0.33 in Q3 2025, and -$0.46 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Janux Therapeutics | 985.11 Mn | 985.11 Mn | - | -1.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.27 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.05 |
| Mar 31, 2024 | -0.08 |
| Sep 30, 2023 | -1.05 |
| Jun 30, 2023 | -0.57 |
| Mar 31, 2023 | -0.54 |
| Dec 31, 2022 | -53.10 |
| Sep 30, 2022 | -0.48 |
| Jun 30, 2022 | -0.46 |
| Mar 31, 2022 | -0.39 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2020 | -10.15 |